PROSOMNUS INC (OSA)
US50535E1082 - Common Stock
OSA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. OSA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, OSA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
OSA had negative earnings in the past year.
In the past year OSA has reported a negative cash flow from operations.
1.2 Ratios
With a Return On Assets value of -49.44%, OSA is not doing good in the industry: 67.18% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.44% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-65.61%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OSA has a Gross Margin of 52.38%. This is comparable to the rest of the industry: OSA outperforms 47.18% of its industry peers.
OSA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.38% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
OSA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OSA has about the same amount of shares outstanding.
Compared to 1 year ago, OSA has an improved debt to assets ratio.
2.2 Solvency
OSA has an Altman-Z score of -11.52. This is a bad value and indicates that OSA is not financially healthy and even has some risk of bankruptcy.
OSA's Altman-Z score of -11.52 is on the low side compared to the rest of the industry. OSA is outperformed by 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -11.52 |
ROIC/WACCN/A
WACC7.85%
2.3 Liquidity
OSA has a Current Ratio of 1.53. This is a normal value and indicates that OSA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.53, OSA is not doing good in the industry: 83.08% of the companies in the same industry are doing better.
A Quick Ratio of 1.38 indicates that OSA should not have too much problems paying its short term obligations.
OSA's Quick ratio of 1.38 is on the low side compared to the rest of the industry. OSA is outperformed by 71.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The earnings per share for OSA have decreased strongly by -28.77% in the last year.
The Revenue has grown by 42.22% in the past year. This is a very strong growth!
EPS 1Y (TTM)-28.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-218.18%
Revenue 1Y (TTM)42.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%41.4%
3.2 Future
Based on estimates for the next years, OSA will show a small growth in Earnings Per Share. The EPS will grow by 4.66% on average per year.
Based on estimates for the next years, OSA will show a very strong growth in Revenue. The Revenue will grow by 30.56% on average per year.
EPS Next Y-101.05%
EPS Next 2Y-25.09%
EPS Next 3Y4.66%
EPS Next 5YN/A
Revenue Next Year41.66%
Revenue Next 2Y33.46%
Revenue Next 3Y30.56%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OSA. In the last year negative earnings were reported.
Also next year OSA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.09%
EPS Next 3Y4.66%
5. Dividend
5.1 Amount
OSA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PROSOMNUS INC
NASDAQ:OSA (4/17/2024, 8:17:27 PM)
After market: 0.44 -0.03 (-6.38%)0.47
-0.05 (-10.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.17M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.44% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.38% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-28.77%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-101.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)42.22%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y